US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 4.270
  • -0.040-0.93%
Close Jul 19 16:00 ET
486.06MMarket Cap-2223P/E (TTM)

Fate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-15.56%-33.35M
46.71%-132.26M
51.40%-36.64M
30.47%-38.27M
46.40%-28.49M
55.33%-28.86M
-52.40%-248.21M
-7.25%-75.39M
-64.93%-55.05M
-65.57%-53.16M
Net income from continuing operations
-154.25%-48M
42.88%-160.93M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
-32.79%-281.72M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
Depreciation and amortization
15.03%4.82M
32.88%18.28M
0.89%4.89M
48.45%4.74M
50.78%4.47M
51.79%4.19M
135.18%13.76M
119.49%4.84M
110.20%3.19M
154.03%2.96M
Other non cash items
102.48%869K
-70.16%-40.86M
102.32%220K
51.58%-1.87M
-5,485.90%-4.2M
-225.31%-35.01M
-32.68%-24.01M
-41.76%-9.47M
75.52%-3.86M
-98.97%78K
Change In working capital
-94.95%614K
155.26%19.18M
87.13%-4.19M
-127.86%-2.82M
1,309.30%14.04M
209.22%12.15M
-1,754.43%-34.71M
-152.99%-32.55M
9.13%10.12M
-152.39%-1.16M
-Change in receivables
-95.39%968K
222.98%36.65M
98.98%-288K
-55.36%1.3M
1,925.69%14.67M
505.49%20.98M
-843.16%-29.8M
-1,970.11%-28.26M
-3.01%2.9M
121.56%724K
-Change in prepaid assets
-61.64%4.57M
170.25%12.88M
77.91%-1.64M
47.45%-1.47M
171.15%4.08M
594.43%11.9M
-500.59%-18.33M
-554.82%-7.41M
-1,006.35%-2.79M
-1,456.79%-5.73M
-Change in payables and accrued expense
77.90%-4.51M
-303.06%-28.94M
-155.89%-1.89M
-122.19%-2.28M
-207.21%-4.37M
-483.82%-20.39M
141.27%14.25M
132.63%3.39M
52.58%10.28M
56.52%4.08M
-Change in other working capital
-22.62%-412K
-70.05%-1.41M
-37.27%-372K
-37.41%-371K
-40.00%-329K
-546.15%-336K
-134.46%-828K
-2,563.64%-271K
-34.33%-270K
-135.61%-235K
Cash from discontinued investing activities
Operating cash flow
-15.56%-33.35M
46.71%-132.26M
51.40%-36.64M
30.47%-38.27M
46.40%-28.49M
55.33%-28.86M
-52.40%-248.21M
-7.25%-75.39M
-64.93%-55.05M
-65.57%-53.16M
Investing cash flow
Cash flow from continuing investing activities
85.37%17.31M
-32.44%112.67M
-14.61%45.35M
-69.14%24.81M
-17.67%33.17M
232.93%9.34M
151.46%166.75M
-25.49%53.11M
3.10%80.38M
3,036.37%40.29M
Net PPE purchase and sale
97.32%-86K
82.70%-6.15M
97.29%-181K
93.49%-565K
78.29%-2.2M
68.19%-3.21M
29.86%-35.57M
63.65%-6.68M
41.12%-8.68M
25.63%-10.13M
Net investment purchase and sale
38.67%17.4M
-41.27%118.82M
-23.84%45.53M
-71.51%25.37M
-29.85%35.37M
310.33%12.55M
174.02%202.32M
-33.31%59.79M
-3.93%89.05M
311.66%50.42M
Cash from discontinued investing activities
Investing cash flow
85.37%17.31M
-32.44%112.67M
-14.61%45.35M
-69.14%24.81M
-17.67%33.17M
232.93%9.34M
151.46%166.75M
-25.49%53.11M
3.10%80.38M
3,036.37%40.29M
Financing cash flow
Cash flow from continuing financing activities
46,029.47%95.49M
-99.08%85K
-111.87%-180K
0
-98.30%58K
-92.60%207K
-97.97%9.21M
-55.62%1.52M
-81.28%1.49M
-8.42%3.41M
Net common stock issuance
--75.19M
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
9,704.35%20.3M
-99.08%85K
-111.87%-180K
--0
-98.30%58K
-92.60%207K
-77.76%9.21M
-56.02%1.52M
-94.80%1.49M
-8.39%3.41M
Cash from discontinued financing activities
Financing cash flow
46,029.47%95.49M
-99.08%85K
-111.87%-180K
--0
-98.30%58K
-92.60%207K
-97.97%9.21M
-55.62%1.52M
-81.28%1.49M
-8.42%3.41M
Net cash flow
Beginning cash position
-25.49%57.05M
-48.55%76.56M
-50.15%48.51M
-12.09%61.98M
-28.41%57.25M
-48.55%76.56M
-18.49%148.81M
-32.61%97.32M
-23.27%70.5M
-34.26%79.97M
Current changes in cash
511.39%79.45M
72.99%-19.51M
141.12%8.54M
-150.22%-13.47M
149.99%4.73M
71.95%-19.31M
-113.99%-72.25M
-571.50%-20.76M
-48.94%26.82M
68.19%-9.47M
End cash Position
138.44%136.5M
-25.49%57.05M
-25.49%57.05M
-50.15%48.51M
-12.09%61.98M
-28.41%57.25M
-48.55%76.56M
-48.55%76.56M
-32.61%97.32M
-23.27%70.5M
Free cash flow
-4.27%-33.44M
51.22%-138.42M
55.14%-36.82M
39.05%-38.84M
51.50%-30.69M
57.07%-32.07M
-32.87%-283.77M
7.44%-82.07M
-32.45%-63.72M
-38.41%-63.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -15.56%-33.35M46.71%-132.26M51.40%-36.64M30.47%-38.27M46.40%-28.49M55.33%-28.86M-52.40%-248.21M-7.25%-75.39M-64.93%-55.05M-65.57%-53.16M
Net income from continuing operations -154.25%-48M42.88%-160.93M21.72%-44.12M45.94%-45.17M30.68%-52.76M71.26%-18.88M-32.79%-281.72M17.86%-56.36M-92.95%-83.56M-38.04%-76.11M
Depreciation and amortization 15.03%4.82M32.88%18.28M0.89%4.89M48.45%4.74M50.78%4.47M51.79%4.19M135.18%13.76M119.49%4.84M110.20%3.19M154.03%2.96M
Other non cash items 102.48%869K-70.16%-40.86M102.32%220K51.58%-1.87M-5,485.90%-4.2M-225.31%-35.01M-32.68%-24.01M-41.76%-9.47M75.52%-3.86M-98.97%78K
Change In working capital -94.95%614K155.26%19.18M87.13%-4.19M-127.86%-2.82M1,309.30%14.04M209.22%12.15M-1,754.43%-34.71M-152.99%-32.55M9.13%10.12M-152.39%-1.16M
-Change in receivables -95.39%968K222.98%36.65M98.98%-288K-55.36%1.3M1,925.69%14.67M505.49%20.98M-843.16%-29.8M-1,970.11%-28.26M-3.01%2.9M121.56%724K
-Change in prepaid assets -61.64%4.57M170.25%12.88M77.91%-1.64M47.45%-1.47M171.15%4.08M594.43%11.9M-500.59%-18.33M-554.82%-7.41M-1,006.35%-2.79M-1,456.79%-5.73M
-Change in payables and accrued expense 77.90%-4.51M-303.06%-28.94M-155.89%-1.89M-122.19%-2.28M-207.21%-4.37M-483.82%-20.39M141.27%14.25M132.63%3.39M52.58%10.28M56.52%4.08M
-Change in other working capital -22.62%-412K-70.05%-1.41M-37.27%-372K-37.41%-371K-40.00%-329K-546.15%-336K-134.46%-828K-2,563.64%-271K-34.33%-270K-135.61%-235K
Cash from discontinued investing activities
Operating cash flow -15.56%-33.35M46.71%-132.26M51.40%-36.64M30.47%-38.27M46.40%-28.49M55.33%-28.86M-52.40%-248.21M-7.25%-75.39M-64.93%-55.05M-65.57%-53.16M
Investing cash flow
Cash flow from continuing investing activities 85.37%17.31M-32.44%112.67M-14.61%45.35M-69.14%24.81M-17.67%33.17M232.93%9.34M151.46%166.75M-25.49%53.11M3.10%80.38M3,036.37%40.29M
Net PPE purchase and sale 97.32%-86K82.70%-6.15M97.29%-181K93.49%-565K78.29%-2.2M68.19%-3.21M29.86%-35.57M63.65%-6.68M41.12%-8.68M25.63%-10.13M
Net investment purchase and sale 38.67%17.4M-41.27%118.82M-23.84%45.53M-71.51%25.37M-29.85%35.37M310.33%12.55M174.02%202.32M-33.31%59.79M-3.93%89.05M311.66%50.42M
Cash from discontinued investing activities
Investing cash flow 85.37%17.31M-32.44%112.67M-14.61%45.35M-69.14%24.81M-17.67%33.17M232.93%9.34M151.46%166.75M-25.49%53.11M3.10%80.38M3,036.37%40.29M
Financing cash flow
Cash flow from continuing financing activities 46,029.47%95.49M-99.08%85K-111.87%-180K0-98.30%58K-92.60%207K-97.97%9.21M-55.62%1.52M-81.28%1.49M-8.42%3.41M
Net common stock issuance --75.19M------------------0----------------
Proceeds from stock option exercised by employees 9,704.35%20.3M-99.08%85K-111.87%-180K--0-98.30%58K-92.60%207K-77.76%9.21M-56.02%1.52M-94.80%1.49M-8.39%3.41M
Cash from discontinued financing activities
Financing cash flow 46,029.47%95.49M-99.08%85K-111.87%-180K--0-98.30%58K-92.60%207K-97.97%9.21M-55.62%1.52M-81.28%1.49M-8.42%3.41M
Net cash flow
Beginning cash position -25.49%57.05M-48.55%76.56M-50.15%48.51M-12.09%61.98M-28.41%57.25M-48.55%76.56M-18.49%148.81M-32.61%97.32M-23.27%70.5M-34.26%79.97M
Current changes in cash 511.39%79.45M72.99%-19.51M141.12%8.54M-150.22%-13.47M149.99%4.73M71.95%-19.31M-113.99%-72.25M-571.50%-20.76M-48.94%26.82M68.19%-9.47M
End cash Position 138.44%136.5M-25.49%57.05M-25.49%57.05M-50.15%48.51M-12.09%61.98M-28.41%57.25M-48.55%76.56M-48.55%76.56M-32.61%97.32M-23.27%70.5M
Free cash flow -4.27%-33.44M51.22%-138.42M55.14%-36.82M39.05%-38.84M51.50%-30.69M57.07%-32.07M-32.87%-283.77M7.44%-82.07M-32.45%-63.72M-38.41%-63.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg